Home › NDC Lookup › RxCUI directory › RxCUI 2479567

300 ML labetalol hydrochloride 1 MG/ML Injection — RxCUI 2479567

RxNorm drug concept · Semantic clinical drug
RxCUI 2479567 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2479567
Official name300 ML labetalol hydrochloride 1 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslabetalol hydrochloride 300 MG per 300 ML Injection; labetalol hydrochloride 300 MG in 300 ML Injection
FDA products mapped5
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Labetalol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Labetalol is used to lower high blood pressure (hypertension). The tablet form is for ongoing daily management of hypertension, and can be used on its own or with other blood press...
  • Please don't stop labetalol on your own, even if you feel great — this is really important. Stopping suddenly, especially if you have coronary artery disease (even undiagnosed), ca...
  • Is it okay to stop taking labetalol if I feel fine?
  • Yes, this is a known effect. Labetalol lowers blood pressure more when you're standing than lying down, which can cause lightheadedness when you get up quickly — especially 2 to 4...
📖 Read our full Labetalol guide →

🕸️ Concept Web — How 300 ML labetalol hydrochloride 1 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 300 ML labetalol hydrochloride 1 MG/ML Injection RxCUI 2479567

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Labetalol 6185
    • Labetalol hydrochloride 202693
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Labetalol Injection 2477888
    • Labetalol hydrochloride Injection 2645366
    • Labetalol Injectable Product 1161585
    • Labetalol hydrochloride Injectable Product 2662255
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Labetalol hydrochloride 1 MG/ML 2479563

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Labetalol hydrochloride 1 MG/ML SCDC · 2479563
  • Labetalol Injection SCDF · 2477888
  • Labetalol hydrochloride Injection SCDFP · 2645366
  • Labetalol Injectable Product SCDG · 1161585
  • Labetalol hydrochloride Injectable Product SCDGP · 2662255

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 2479567 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9183-10 10 VIAL in 1 CARTON (0143-9183-10) / 4 mL in 1 VIAL (0143-9... Labetalol Hydrochloride Hikma Pharmaceuticals USA Inc. 2025-08-28
00143-9363-10 10 BAG in 1 BOX (0143-9363-10) / 100 mL in 1 BAG (0143-9363... Labetalol HCl in Sodium Chloride Hikma Pharmaceuticals USA Inc. 2020-11-09
00143-9364-10 10 BAG in 1 BOX (0143-9364-10) / 200 mL in 1 BAG (0143-9364... Labetalol HCl in Sodium Chloride Hikma Pharmaceuticals USA Inc. 2020-11-09
00143-9365-10 10 BAG in 1 BOX (0143-9365-10) / 300 mL in 1 BAG (0143-9365... Labetalol HCl in Sodium Chloride Hikma Pharmaceuticals USA Inc. 2020-11-09
00143-9366-10 10 BAG in 1 BOX (0143-9366-10) / 200 mL in 1 BAG (0143-9366... Labetalol HCl in Dextrose Hikma Pharmaceuticals USA Inc. 2020-11-09
Observed labelers: Hikma Pharmaceuticals USA Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1921 Inj labetalol hcl hikma, 5mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.